Read & Publish agreement with Elsevier 2024-2028
© Adobe Stock
In the framework of the Swiss national strategy on Open Access, swissuniversities, on behalf of the Swiss Higher Education Institutions, and Elsevier signed a second transformative agreement Read & Publish (2024-2028). This new contract covers Elsevier's entire journal portfolio, including Cell Press and the Lancet titles.
After a contractless period at the beginning of the year, and continued negotiations in the following months, the new agreement with the scientific publisher Elsevier finally comes into force at EPFL and other Swiss participating universities.
EPFL affiliated corresponding authors can publish in Open Access at no additional cost in more than 2’500 journals (Elsevier, Cell Press, The Lancet), without any restriction.
The EPFL community will also have a full reading access to this wide portfolio.
The agreement also explicitly regulates the use of artificial intelligence (AI) in connection with licensed content: more information is available on the swissuniversities webpage dedicated to the contract.
Any question?
Contact [email protected] (Scientific Publishing team) for any information on Open Access and publishing options. For any further information about negotiations with academic publishers, please visit go.epfl.ch/negotiations.